Liquid-based preparation for endometrial cytology - Usefulness for predicting the prognosis of endometrial carcinoma preoperatively

Cancer Cytopathology

Volumn 117, Issue 4, 2009, Pages 254-263

  Watanabe, Jun ^a,b   Nishimura, Yukari ^a   Tsunoda, Shinpei ^b   Kawaguchi, Miwa ^b   Okayasu, Isao ^b   Kuramoto, Hiroyuki ^a,b,c  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kanagawa Health Service Association   (Japan)

Author keywords

Clinicopathologic parameter; Endometrial carcinoma; Endometrial cytology; Immunocytochemistry; Immunohistochemistry; Liquid based cytology; Prognosis

Indexed keywords

CYCLIN A; ESR1 PROTEIN, HUMAN; ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR B; PROTEIN P53;

ADULT; AGED; ARTICLE; CYTOLOGY; ENDOMETRIUM; ENDOMETRIUM TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADULT; AGED; CYCLIN A; CYTOLOGICAL TECHNIQUES; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; RECEPTORS, PROGESTERONE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 69849087730     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20035     Document Type: Article

References (34)

1. Nakagawa-Okamura C, Sato S, Tsuji I, et al. Effectiveness of mass screening for endometrial cancer. Acta Cytol. 2002;46:277-283.
2. Imai M, Jobo T, Sato R, Kawaguchi M, Kuramoto H. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus - usefulness and limitations. Eur J Gynaecol Oncol. 2001;22:217-220.
3. Jobo T, Imai M, Kawaguchi M, Kenmochi M, Kuramoto H. Successful conservative treatment of endometrial carcinoma permitting subsequent pregnancy: report of 2 cases. Eur J Gynaecol Oncol. 2000;21:119-122.
4. Kyushima N, Watanabe J, Hata H, Jobo T, Kameya T, Kuramoto H. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables. J Cancer Res Clin Oncol. 2002;128:307-312.
5. Shih HC, Shiozawa T, Kato K, et al. Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator. Hum Pathol. 2003;34:471-478.
6. Jones MW, Kounelis S, Hsu C, et al. Prognostic value of p53 and K-ras-2 topographic genotyping in endometrial carcinoma: a clinicopathologic and molecular comparison. Int J Gynecol Pathol. 1997;16:354-360.
7. Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks CB. Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level. Int J Gynecol Pathol. 2004;23:129-137.
8. Hu K, Zhong G, He F. Expression of estrogen receptors ERa and ERb in endometrial hyperplasia and adenocarcinoma. Int J Gynecol Cancer. 2005;15:537-541.
9. Bircan S, Ensari A, Ozturk S, Erdogan N, Dundar I, Ortac F. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium. Pathol Oncol Res. 2005;11:32-39.
10. Mylonas I, Jeschke U, Shabani N, et al. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR). Anticancer Res. 2005;25:1679-1686.
11. Miyamoto T, Watanabe J, Hata H, et al. Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma. J Steroid Biochem Mol Biol. 2004;92:111-118.
12. Arnett-Mansfield RL, deFazio A, Wain GV, et al. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res. 2001;61:4576-4582.
13. Buccoliero AM, Gheri CF, Castiglione F, et al. Liquidbased endometrial cytology in the management of sonographically thickened endometrium. Diagn Cytopathol. 2007;35:398-402.
14. Kamata Y, Watanabe J, Hata H, Hamano M, Kuramoto H. Quantitative study on the correlation between p53 gene mutation and its expression in endometrial carcinoma cell lines. Eur J Gynaecol Oncol. 2004;25:55-60.
15. Papaefthimiou M, Symiakaki H, Mentzelopoulou P, et al. Study on the morphology and reproducibility of the diagnosis of endometrial lesions utilizing liquid-based cytology. Cancer (Cancer Cytopathol). 2005;105:56-64.
16. Maksem JA. Performance characteristics of the Indiana University Medical Center endometrial sampler (Tao Brush) in an outpatient office setting, first year's outcomes: recognizing histological patterns in cytology preparations of endometrial brushings. Diagn Cytopathol. 2000;22:186-195.
17. Maksem JA, Knesel E. Liquid fixation of endometrial brush cytology ensures a well-preserved, representative cell sample with frequent tissue correlation. Diagn Cytopathol. 1996;14:367-373.
18. Papaefthimiou M, Symiakaki H, Mentzelopoulou P, et al. The role of liquid-based cytology associated with curettage in the investigation of endometrial lesions from postmenopausal women. Cytopathology. 2005;6:32-39.
19. Garcia F, Barker B, Davis J, et al. Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding. J Repro Med. 2003;48:882-888.
20. Ono E, Kuramoto H. Diagnosis of the histological grading of endometrial carcinoma by cytology. J Jpn Soc Cytol. 1988;27:449-458.
21. Sass MA. Use of a liquid-based, thin-layer Pap test in a community hospital. Impact on cytology performance and productivity. Acta Cytol. 2004;48:17-22.
22. Studeman KD, Ioffe OB, Puszkiewicz J, Sauvegeot J, Henry MR. Effect of cellularity on the sensitivity of detecting squamous lesions in liquid-based cervical cytology. Acta Cytol. 2003;47:605-610.
23. Beerens E, Van Renterghem L, Praet M, et al. Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes. Cytopathology. 2005;16:199-205.
24. Davis-Devine S, Day SJ, Freund GG. Test performance comparison of inform HPV and Hybrid Capture 2 highrisk HPV DNA tests using the SurePath liquid-based Pap test as the collection method. Am J Clin Pathol. 2005;124:24-30.
25. Guo G, Hu L, Balga M, He Z, Hughson MD. The predictive value of p16 (INK4a) and Hybrid Capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia. Am J Clin Pathol. 2004;122:894-901.
26. Negri G, Egarter-Vigl E, Kasal A, Romano F, Haitel A, Mian C. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol. 2003;27:187-193.
27. Saqi A, Pasha TL, McGrath CM, Yu GH, Zhang P, Gupta P. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Diagn Cytopathol. 2002;27:365-370.
28. Tisserand P, Fouquet C, Marck V, et al. ThinPrep-processed fine-needle samples of breast are effective material for RNA- and DNA-based molecular diagnosis: application to p53 mutation analysis. Cancer (Cancer Cytopathol). 2003;99:223-232.
29. Leung SW, Bedard YC. Estrogen and progesterone receptor contents in ThinPrep-processed fine-needle aspirates of breast. Am J Clin Pathol. 1999;112:50-56.
30. Bedard YC, Pollett AF, Leung SW, O'Malley FP. Assessment of thin-layer breast aspirates for immunocytochemical evaluation of HER2 status. Acta Cytol. 2003;47:979-984.
31. Nishimura Y, Watanabe J, Jobo T, Hattori M, Arai T, Kuramoto H. Cytological scoring of endometrioid adenocarcinoma of the endometrium - correlation with histological grade and clinicopathological factors. Cancer (Cancer Cytopathol). 2005;105:8-12.
32. Watanabe J, Kamata Y, Kanai T, et al. Expression of cell cycle regulation in endometrial adenocarcinoma. In: Kuramoto H, Nishida M, eds. Cell and Molecular Biology of Endometrial Carcinoma. Tokyo, Japan:Springer-Verlag; 2003:225-236.
33. Oreskovic S, Babic D, Kalafatic D, Barisic D, Beketic-Oreskovic L. Significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma. Gynecol Oncol. 2004;93:34-40.
34. Engelsen IB, Stefansson I, Akslen LA, Salvesen HB. Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas. Am J Obstet Gynecol. 2006;195:979-986.